Seeking Alpha

BiotechInvestor...'s  Instablog

BiotechInvestor.com
Send Message
Shane Skinner has invested in biotech companies for almost 20 years and placed over $2.6 million in biotech stock trades in 2013. He has held various financial leadership positions over the past 17 years throughout the United States and Europe including Chief Financial Officer. Shane graduated... More
My blog:
BiotechInvestor.com
  • Daily Dose - Oncogenex, KaloBios, Merrimack 0 comments
    Feb 27, 2014 7:01 PM | about stocks: OGXI, KBIO, MACK

    A number of buy recommendations came out this morning for some of my holdings and one reports earnings after market close.

    Oncogenex OGXI was upgraded to buy by CRT Capital with a $20 price target. Oncogenex will report phase 3 results of it's prostate cancer drug, Custirsen, sometime in Q2. The stock has a discounted market cap of $172 million for a company with three phase 3 and seven phase 2 trials running which is why I hold a significant position.

     

    OGXI

     

    11.695

       

    5,000

    $11.01

    $3,377.46

    6.13%

    $58,475.00

    KaloBios KBIO was upgraded to buy by JMP Securities with a $8 price target. The company took a recent hit after it's flagship Asthma drug failed in a phase 2 study but the company has other compounds with promise and great partnerships with Sanofi and Novartis so I'm looking to buy at these levels.

    Merrimack MACK will report Q4 and full year results after the bell today. The stock has been on a tear since pushing back expected results from it's pancreatic cancer drug, MM-398, about six months due to longer overall survival trends. Merrimack is my pick up the year as pancreatic cancer is one of the deadliest and has few treatment options (think the late Patrick Swayze) so a survival benefit would be outstanding for patients and for the Merrimack.

     

    MACK

     

    5.005

       

    15,400

    $2.9977

    $30,871.84

    66.81%

    $77,077.00

                                                                                      

    Disclosure: I am long MACK, OGXI.

    Themes: Biotech Stocks: OGXI, KBIO, MACK
Back To BiotechInvestor.com's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.